Loading organizations...
Loading organizations...
Drug discovery platform for targeted protein degradation therapeutics.
Degron Therapeutics has raised $22.3M across 2 funding rounds.
Degron Therapeutics has raised $22.3M in total across 2 funding rounds.
Degron Therapeutics has raised $22.3M in total across 2 funding rounds.
Degron Therapeutics's investors include Sujuan Ba, jing yu, Baidu Ventures, Co-win Ventures, Dyee Capital, NeuX Capital.
Degron Therapeutics has raised $22.3M across 2 funding rounds. Most recently, it raised $290K Series A in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 27, 2023 | $290K Series A | Sujuan Ba | |
| Jun 10, 2022 | $22.0M Series A | jing yu | Baidu Ventures, Co-win Ventures, Dyee Capital, NeuX Capital |